DRG 939 Overview

DRG 939 covers inpatient cases involving operating room procedures for encounters coded as other contact with health services when a Major Complication or Comorbidity is present. This Diagnosis-Related Group groups patients whose principal reason for admission is an operative intervention in the setting of additional serious comorbid conditions that increase resource use. It matters for Medicare payment because the presence of a Major Complication or Comorbidity elevates the relative weight and reimbursement compared with similar cases without such comorbidity. Hospitals and coders must accurately capture the operative procedure and the Major Complication or Comorbidity to ensure appropriate classification and payment.

• Perioperative complication reduction trials assessing enhanced surgical protocols: randomized or quasi-experimental studies evaluate multimodal perioperative care bundles (including infection prevention, optimized anesthesia, and standardized intraoperative monitoring) for patients undergoing operating room procedures coded under DRG 939, particularly those admitted for procedures linked to diagnoses of other contact with health services and with major complication or comorbidity (MCC). These trials typically enroll high-risk adult inpatients who require O.R. procedures and have significant comorbid conditions, aiming to reduce surgical site infections, unplanned returns to the operating room, and in-hospital mortality. Findings are directly relevant to providers for improving clinical pathways and to payers because reductions in complications shorten length of stay and lower costly downstream resource use associated with MCCs.
• Comparative effectiveness studies of surgical approach or timing in patients with acute conditions and complex comorbidity: observational or pragmatic randomized studies compare different operative strategies (for example, minimally invasive versus open techniques, or immediate versus delayed surgery) in populations admitted with diagnoses that reflect other contact with health services complicated by MCCs. These studies focus on intermediate outcomes such as blood loss, transfusion rates, ICU utilization, and composite adverse events in patients whose baseline risk is elevated by chronic conditions captured as MCC. Results inform clinical decision-making about which approaches yield better functional recovery and resource utilization, helping hospitals and payers optimize care pathways and allocate OR and critical care resources efficiently.
• Post-discharge outcome and readmission risk prediction studies targeting patients after O.R. procedures with MCC: cohort studies and predictive-model development research examine post-discharge trajectories, rates and causes of 30- and 90-day readmission, functional outcomes, and costs for survivors of operative admissions categorized in DRG 939. These investigations enroll heterogeneous surgical patients with substantial comorbidity burden to identify modifiable in-hospital factors (e.g., discharge planning, home health referrals, medication reconciliation) that predict readmission and post-acute care needs. The relevance for providers and payers is high because improved discharge strategies can reduce preventable readmissions and downstream spending while improving patient safety and continuity of care.